Two Seas Capital LP Has $77.83 Million Stake in Sotera Health Company $SHC

Two Seas Capital LP increased its stake in Sotera Health Company (NASDAQ:SHC) by 30.8% in the 4th quarter, HoldingsChannel reports. The fund owned 4,412,106 shares of the company’s stock after acquiring an additional 1,038,878 shares during the period. Sotera Health accounts for approximately 1.6% of Two Seas Capital LP’s holdings, making the stock its 7th largest holding. Two Seas Capital LP’s holdings in Sotera Health were worth $77,830,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in SHC. Empowered Funds LLC boosted its holdings in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after acquiring an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after acquiring an additional 43,471 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Sotera Health by 125.5% in the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after acquiring an additional 14,018 shares in the last quarter. Creative Planning boosted its holdings in shares of Sotera Health by 15.3% in the second quarter. Creative Planning now owns 20,186 shares of the company’s stock valued at $224,000 after acquiring an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of Sotera Health by 4.2% in the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock valued at $3,549,000 after acquiring an additional 12,758 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 15.36% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

SHC has been the subject of several recent analyst reports. Barclays decreased their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Piper Sandler reissued an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Citigroup increased their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Finally, The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research note on Friday. They set a “buy” rating and a $20.00 target price for the company. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $20.29.

Sotera Health Stock Up 0.3%

Shares of NASDAQ:SHC opened at $15.62 on Friday. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The company has a market cap of $4.45 billion, a PE ratio of 38.10 and a beta of 1.79. Sotera Health Company has a 52 week low of $10.80 and a 52 week high of $19.85. The firm has a 50 day simple moving average of $15.37 and a 200 day simple moving average of $16.36.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, research analysts expect that Sotera Health Company will post 0.86 earnings per share for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.